03/26/2026
If this is successful, it would mean everything for mold sufferers too!!!
https://www.facebook.com/share/1Dwsd5xSPX/?mibextid=wwXIfr
Scientists created an antibody that can eradicate an infection that affects 95% of the global population.
The Epstein-Barr virus (EBV) is one of the world’s most pervasive pathogens, infecting nearly 95% of humans and persisting for life. While widely known for causing mononucleosis, EBV is also a primary driver of several cancers, including lymphomas, and has been linked to severe neurological and chronic conditions. Scientists at Fred Hutch Cancer Center have now achieved a significant breakthrough by developing human monoclonal antibodies designed to block the virus's entry into human immune cells. By targeting specific proteins the virus uses to attach and invade, this new approach has successfully prevented infection in advanced laboratory models, offering a potential solution to a decades-old medical challenge.
This development is particularly critical for the more than 128,000 Americans who undergo organ or bone marrow transplants annually. In these vulnerable patients, EBV can reactivate and trigger post-transplant lymphoproliferative disorder, a life-threatening form of cancer with few preventative options. The researchers envision a future where high-risk individuals receive antibody infusions to neutralize the virus before it can cause harm. Although human clinical trials are the next necessary step, this discovery represents a major leap toward controlling a quietly dangerous virus that has eluded effective prevention since its discovery.
source: Fred Hutch Cancer Center. (2026). Scientists develop first-of-its-kind antibody to block Epstein-Barr virus.
